|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
RED CELLS
From the Department of Microbiology and Infectious
Diseases, and the Immunology Research Group, University of Calgary,
Alberta, Canada; and the Faculty of Tropical Medicine, Mahidol
University, Bangkok, Thailand.
Plasmodium falciparum-infected erythrocytes (IRBCs)
have been shown to interact with a number of endothelial adhesion
molecules expressed on transfectants, on cell lines, and as immobilized purified receptor proteins under flow conditions. However, the experiments were designed in such a way that maximal numbers of adhesion molecules were provided as substratum. Whether the interactive events actually occur on microvascular endothelium, where the distribution and expression of adhesion molecules may be less, remains
undetermined. In this study, the cytoadherance of IRBCs on human dermal
microvascular endothelial cells (HDMECs) as a model of human
microvasculature was examined. IRBCs were observed to tether, roll, and
adhere on resting HDMECs, which constitutively expressed CD36 and
intercellular adhesion molecule-1 (ICAM-1) at an optimal shear stress
of 1 dyne/cm2. Stimulation of HDMECs with tumor necrosis
factor- Plasmodium falciparum malaria
remains a major cause of morbidity and mortality in the
tropics.1 The pathogenicity of the parasite results from
its potential to multiply to high parasite burdens2 and its
unique ability to adhere to capillary and postcapillary venular
endothelium during the second half of its 48-hour life cycle, a process
that is called cytoadherance.3 The resulting sequestration
of infected erythrocytes (IRBCs) and microcirculatory obstruction have
been proposed to be the basis of the multiorgan dysfunction seen in
this infection.4
In the past few years, there has been increasing recognition that
cytoadherance may be mediated sequentially by a number of endothelial
adhesion molecules under physiological flow conditions.5-7 IRBCs from clinical parasite isolates have been shown to tether and
then roll on CD36, intercellular adhesion molecule-1 (ICAM-1), P-selectin, and vascular cell adhesion molecule (VCAM-1), but not
E-selectin.6 Significant adhesion under shear is almost exclusive to CD36. Although some IRBCs bypass the rolling event and are
arrested on CD36 immediately after tethering, there is strong evidence
that the molecules that support rolling can contribute to
CD36-dependent adhesion. On C32 melanoma cells, which coexpress CD36
and ICAM-1, inhibition of rolling by an anti-ICAM-1 antibody reduces
the subsequent adhesion of some parasite isolates to
CD36.6 Similarly, inhibition of rolling by an
anti-P-selectin antibody reduces IRBC adhesion to CD36 on activated
platelets.7 However, all these studies have been conducted
with the use of cell lines and purified receptor proteins, which
ensured that maximal numbers of adhesion molecules were provided as
substratum. Whether the same synergistic adhesive interactions occur on
microvascular endothelial cells, where the distribution and expression
of adhesion molecules is less, has not been determined.
The current study examined the interactions of IRBCs with multiple
adhesion molecules in a model of human microvascular endothelial cells
under flow conditions in vitro. We used human dermal microvascular endothelial cells (HDMECs) because they express CD36, which is absent
on the more commonly used human umbilical vein endothelial cells
(HUVECs). Moreover, HDMECs constitutively express ICAM-1 and can be
induced to express VCAM-1 and P-selectin by cytokines.8,9 Our results indicate that up-regulation of ICAM-1 and induction of
VCAM-1 expression by tumor necrosis factor- Tissue culture reagents and antibodies
Parasites
Endothelial cell isolation and culture HDMECs were harvested from discarded neonatal human foreskin as described previously.10 The protocol was approved by the Ethics Committee of the University of Calgary. Briefly, foreskins were dissected into 2- to 3-mm2 segments, which were digested at 4°C for 16 hours in supplemented M199 containing 0.5 mg/mL collagenase type 1A (Boerhringer Mannheim Biochemicals, Indianapolis, IN). Microvessels were released from digested tissue segments by compressing the tissue segments gently with a spatula. To remove large debris, vessel preparations were passed through a 100-µm nylon mesh (Becton Dickinson, San Jose, CA). The cells were collected by centrifugation at 200g for 10 minutes, and the resulting cell pellets were resuspended in endothelial basal medium (EBM-2) with supplements supplied by the manufacturer (Clonetics, San Diego, CA). The cells were seeded in gelatin-coated tissue culture dishes. Only cell preparations that were greater than 95% positive for von Willebrand factor and platelet/endothelial cell adhesion molecule-1 (PECAM-1) expression by immunohistochemistry were maintained for flow experiments. The HDMECs were used from passage 1 to 7, during which adhesion molecule expression at rest and on stimulation was shown to be stable. Each set of experiments was performed on at least 3 different skin preparations.Cytokines Recombinant human TNF- , interferon- (IFN-) and OSM were
purchased from R & D Systems, Inc (Minneapolis, MN). The concentration of cytokines used for the stimulation of HDMECs in 35-mm tissue culture
dishes (Corning, New York, NY) were as follows: TNF-, 5 to 50 ng/mL;
IFN-, 10 to 100 ng/mL; and OSM, 1 to 20 ng/mL.
Antibodies The monoclonal antibodies (MoAbs) used were known to specifically inhibit the binding of IRBCs to the respective adhesion molecules.6 OKM5 (anti-CD36) was a kind gift of Ortho Diagnostics System (Raritan, NJ); 84H10 (anti-ICAM-1) was purchased from R & D Systems; 4B9 (anti-VCAM-1)11 was a kind gift of Dr R. Lobb, Biogen (Boston, MA). The anti-P-selectin MoAbs GA6, which inhibits neutrophil and HL-60 cell interaction with P-selectin12; AK-413; and AC1.2, which recognizes the short consensus repeat of P-selectin,14 were provided by Dr H. K. Webster, Becton Dickinson Immunocytometry Systems (San Jose, CA). In inhibition studies, HDMEC monolayers were preincubated with the MoAbs at 10 µg/mL Hanks' balanced salt solution at 37°C for 30 minutes before being used in flow experiments.Production and characterization of an inhibitory anti-P-selectin moAb Monoclonal antibodies against human P-selectin were raised by immunizing Balb/c mice intraperitoneally with 20 µg of recombinant human P-selectin (rhP-selectin) (gift of Dr R. P. McEver, University of Oklahoma, Oklahoma City) in complete Freund's adjuvant (CFA), and boosted intraperitoneally 42 days later with 10 µg of rhP-selectin in incomplete CFA. After an additional 10 days, 4 days before fusion, 4 µg of rhP-selectin in phosphate-buffered saline was injected intraperitoneally. Splenocytes were fused with Sp2/mouse interleukin 6 (IL-6) myeloma cells with the use of polyethylene glycol 1500.15 Hybridomas were screened by means of an enzyme-linked immunosorbent assay. Cells from positive wells were cloned by limiting dilution. Supernatants from wells containing single clones were tested for their ability to inhibit IRBC rolling on immobilized P-selectin as previously described.7 A single inhibitory MoAb, TS10-6-6, was identified from 26 supernatants tested by this method. Clone TS10-6-6 cells were cultured in serum-free medium until the cells died. The spent supernatant was collected and frozen in aliquots at 20°C. The
antibody was determined to be an immunoglobulin G1 (IgG1) and
recognized nonreduced rhP-selectin in a Western blot. It also
recognized cell-bound P-selectin expressed on Chinese hamster ovary
(CHO) transfectants16 to the same extent as the commercial MoAb AK-4, but did not label untransfected CHO cells or
HDMECs stimulated with TNF-. Finally, TS10-6-6 inhibited the rolling
of both leukocytes and IRBCs on immobilized P-selectin. In contrast,
MoAb GA6 inhibited only leukocyte rolling. MoAb AC1.2 was not
inhibitory for either cell type. Collectively, these findings confirmed
the functional specificity of TS10-6-6 for P-selectin.
Determination of adhesion molecule expression on HDMECs For resting and TNF--stimulated HDMECs, cells were detached
from tissue culture plates with the use of 0.05% trypsin in 0.53 mmol/L EDTA. They were incubated with an unlabeled anti-CD36, anti-ICAM-1, anti-VCAM-1, or TS10-6-6 for 30 minutes at 4°C. The stained cells were washed, and a fluorescein-labeled antimouse IgG1 was
added for 30 minutes at 4°C. Control cells were stained with the
second antibody only. Washed cells were analyzed on a fluorescent cell
sorter (Becton Dickinson). HDMECs stimulated with OSM were detached
with EDTA alone (10 to 20 minutes at room temperature) and stained with
phycoerythrin (PE)-labeled AC1.2 (Becton Dickinson). Control cells
were stained with PE-labeled mouse IgG1 (Becton Dickinson).
Adhesive interactions of malaria under flow IRBC-endothelial cell interactions at fluid shear stresses approximating those in the microvasculature were studied with the use of a parallel plate flow chamber as described.16 A suspension of IRBCs (1% hematocrit, 5% to 7% parasitemia in RPMI 1640, pH 7.2) was drawn through the flow chamber at varying rates with an infusion pump attached to the outlet. At this concentration of IRBCs, attached IRBCs and their motion could be clearly observed with phase contrast objectives (200 ×) and quantitated by analysis of videotaped images. The presence of intracellular parasites in interacting erythrocytes was confirmed by experiments in which IRBCs were labeled with rhodamine 6G (1:10 of 0.05%, 5 minutes), and the adhesive interactions were observed by epi-illumination at 510 to 560 nm, with the use of a 590-nm emission filter. Tethering referred to the initial contact between IRBCs and the endothelial monolayer. A rolling IRBC was defined as one that displayed a typical end-on-end rolling motion at a velocity of less than 150 µm/s, compared with a flow rate of red blood cells greater than 1000 µm/s, and a velocity greater than 150 µm/s for noninteracting cells in close proximity to the endothelial monolayer. The flux of rolling IRBCs was determined as the number that rolled past a fixed line on the monitor for the duration of the experiment, and expressed as the number of rolling IRBCs per minute per square millimeter. An IRBC was considered adherent if it remained stationary for more than 10 seconds, and the results were expressed as the number of adherent IRBCs per square millimeter of surface area.Statistical analysis All data are presented as mean ± SEM. Data were compared by ANOVA for paired samples, followed by post hoc analysis with Dunn's test for multiple comparisons. Probabilities of .05 or less were considered statistically significant.
IRBC rolling and adhesion on resting HDMECs is shear dependent The interaction of IRBCs with resting HDMECs was studied at a shear stress of 0.5 to 3 dyne/cm2. IRBCs tethered to HDMECs at all shears tested, but rolling was absent until a threshold shear stress of 0.8 dyne/cm2 was reached (Figure 1). Rolling flux quickly reached a peak at 1 dyne/cm2 and became essentially shear independent thereafter. In contrast, adhesion was highest at 0.5 dyne/cm2 and dropped very quickly to near zero by 2 dyne/cm2. However, once adherent, IRBCs could withstand an increase in shear stress of up to 10 dyne/cm2 (number of adherent IRBCs at 1 dyne/cm2 = 201/mm2 ± 14/mm2 and at 10 dyne/cm2 = 188/mm2 ± 21/mm2 ; n = 3). All remaining experiments in this study were conducted at 1 dyne/cm2. At this shear stress, rolling IRBCs had a mean velocity of 41.79 µm/s ± 1.68 µm/s (based on 50 cells for each isolate).
Types of IRBC-endothelial-cell interactions We observed 3 types of IRBC-endothelial cell interactions on resting and cytokine-stimulated HDMECs. Ninety percent to 100% of the adherent IRBCs from 9 of the 10 clinical isolates studied rolled for various distances before becoming arrested. In only 1 of 10 isolates, 40% ± 5.3% (4 experiments) of the adherent IRBCs bypassed the rolling event and adhered abruptly after tethering. The mean percentage of rolling cells that became adherent was 47% ± 8.8% for the 10 isolates, which meant that nearly half of the IRBCs that rolled did not adhere in the field of observation. The variations in the types of adhesive interaction at least in part reflect the genotypic and phenotypic heterogeneity of wild-type parasite isolates.Adhesion molecule expression on TNF- for
5 or 24 hours resulted in up-regulation of ICAM-1 expression, in terms
of both the percentage of positive cells and the mean fluorescent
intensity. VCAM-1 expression was maximal at 24 hours. The percentage of
CD36+ cells varied from 75% to 100% for different skin
preparations, depending on the location of the
microvessels,17 but was unchanged by the addition of 5 to
50 ng/mL TNF- or 10 to 100 ng/mL IFN- for up to 30 hours. These
results agree with previous reports on adhesion molecule expression on
TNF--stimulated HDMECs.8,10
TNF- to HDMECs for 5 hours and 24 hours
resulted in no increase in the number of rolling cells compared with controls (Figure 3A), but a significantly
greater number of IRBCs were adherent at both time points
(P < .01 and .001, respectively) (Figure 3B).
Accordingly, the percentage of rolling IRBCs that became adherent
increased from 44% ± 8.8% on unstimulated HDMECs to
77% ± 6.5% after 5 hours and 97% ± 4.6% after 24 hours of
TNF- stimulation. To determine which adhesion molecules were
involved in mediating IRBC rolling and adhesion on TNF--stimulated
HDMECs, the inhibitory effect of various receptor-specific MoAbs was
studied. The results are presented in Figures
4 and 5. On
HDMECs stimulated with TNF- for 5 hours, the rolling flux was not
significantly reduced by either anti-CD36 or anti-ICAM-1 alone, but
was significantly reduced in the presence of both antibodies
(P < .05). In contrast, adhesion was more than 90%
inhibited by anti-CD36 (P < .001), whereas inhibition
with anti-ICAM-1 was approximately 40% (P < .05). There
was complete inhibition of adhesion when both antibodies were present
(P < .001). A similar pattern of response to inhibitory antibodies was seen with HDMECs stimulated with TNF- for 24 hours (Figure 5). Significant inhibition of rolling was seen only with anti-ICAM-1 (P < .05), whereas significant inhibition of
adhesion was seen with anti-CD36 (P < .001), anti-ICAM-1
(P < .001), and anti-VCAM-1 (P < .01). Two
irrelevant IgG1 MoAbs at 10 µg/mL had no effect on IRBC rolling or
adhesion on TNF--stimulated HDMECs (data not shown).
OSM promotes IRBC rolling and adhesion to HDMECs HDMECs were stimulated with OSM at 1, 10, and 20 ng/mL for 24 and 48 hours. A dose of 10 ng/mL for 48 hours most consistently induced a small but significant increase in P-selectin surface expression (Figure 6) without affecting the expression of CD36, ICAM-1, or VCAM-1 (data not shown). The induced P-selectin supported the rolling of 184 ± 35 leukocytes per square millimeter (n = 7), which was inhibitable by the MoAb GA6, compared with 12 ± 2 leukocytes per square millimeter on unstimulated HDMECs (S Kerfoot et al, unpublished data).
In contrast to the effect of TNF-
In this study, we tested the hypothesis that IRBCs interact with multiple adhesion molecules on microvascular endothelium under physiological flow conditions and that the different interactions are synergistic in promoting adhesion. We used dermal microvascular endothelial cells as a model system of human microvasculature. HDMECs are the only readily accessible cells that express or can be induced to express all the adhesion molecules (CD36, ICAM-1, P-selectin, and VCAM-1) that have so far been implicated in mediating cytoadherance under flow conditions. These adhesion molecules are of clinical significance as all of them have been demonstrated on the microvasculature of brain, liver, kidney, and lung tissues from patients who died from severe falciparum malaria.11,18 Our results indicate that IRBCs tethered, rolled, and adhered on
both resting and cytokine-stimulated microvascular endothelial cells.
Adhesion was largely via CD36. We have shown previously on CD36
transfectants that the molecule can in fact mediate all 3 phases of
IRBC-endothelial cell interactions, ie, tethering, rolling, and
adhesion.6 However, interaction with CD36 on microvascular endothelium, where the expression of the molecule was much lower than
on the transfectants (mean fluorescent intensity at least a log lower),
did not appear to be sufficient for the arrest of approximately two
thirds of the rolling IRBCs. On the other hand, stimulation with
TNF- In contrast to the pivotal role of CD36 in mediating IRBC adhesion,
rolling of IRBCs appeared to be a more promiscuous event in terms of
both the number of adhesion molecules that can support this interaction
and the mechanisms by which rolling enhances subsequent adhesion to
CD36. On TNF- The most novel obsevation in this present report is the demonstration that P-selectin expression increased the number of rolling as well as adherent cells, indicating an actual increase in the number of IRBCs recruited to the endothelial surface. This finding firmly establishes a major role for P-selectin in mediating cytoadherance to microvascular endothelium under flow conditions and is consistent with the key role of selectins in the initial tethering and rolling of leukocytes in their recruitment to sites of inflammation. There is much evidence to support a proinflammatory role for OSM,
a member of the IL-6 family of cytokines. On HUVECs, OSM induces
P-selectin expression within 15 minutes and E-selectin expression
in 4 hours through interaction with a high-affinity receptor.20 P-selectin induction through gene
transcription is a slower but more sustained process, reaching a peak
between 24 to 32 hours and maintaining it for up to 72 hours.9 As in previous studies involving
HUVECs,9 P-selectin expression on OSM-stimulated HDMEC was
difficult to demonstrate, but its presence was confirmed by the ability
of the stimulated HDMECs, but not unstimulated cells, to support the
rolling and adhesion of leukocytes. Although OSM has not been
specifically studied in relation to human malaria, it is well
documented that IL-6 levels, together with those of TNF- The best studied cyto-adherent ligand on IRBC is P falciparum erythrocyte membrane protein 1 (PfEMP1), which is diverse in size (200 to 350 kd) and antigenically variant.23 The protein is exported from the parasite and linked to the erythrocyte cytoskeleton during the second half of the life cycle. Tryptic fragments of PfEMP1 cleaved from the surface of IRBCs bind to purified CD36, ICAM-1, and thrombospondin.24 PfEMP1 also mediates the adhesion of IRBCs to chondroitin sulfate A (CSA) expressed on syncytiotrophoblasts of the human placenta.25 The domains on PfEMP1 that mediate interaction with CD36, ICAM-1, and CSA have been identified.26-28 Using Western blot analysis and immunoprecipitation, we have recently demonstrated that PfEMP1 is also the ligand for P-selectin (Senczuk et al, unpublished data). Thus P falciparum appears to have evolved the capability of interacting with a number of adhesion molecules by the same variant surface protein. The ultimate goal of any research on cytoadherance is the
development of safe and effective methods of inhibiting or reversing the process. The synergism among multiple adhesion molecules in mediating cytoadherance described in this report could be exploited to
develop antiadhesive strategies. There might even be other adhesion
molecules such as PECAM-1 and
We thank Dr Paul Kubes for reviewing the manuscript, Mrs. Laurie Robertson for the flow cytometry studies, and Dr Carolyn Lane and her colleagues at Valley View Family Practice Clinic, Calgary, Alberta, Canada, for providing the skin specimens.
Submitted January 14, 2000; accepted May 22, 2000.
Supported by the Medical Research Council of Canada; the Alberta Heritage Foundation for Medical Research, Alberta, Canada; and the Wellcome-Mahidol University, Oxford Tropical Medicine Research Programme, funded by the Wellcome Trust of Great Britain.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: May Ho, Department of Microbiology and Infectious Diseases, 3330 Hospital Dr NW, Calgary, Alberta, Canada T2N 4N1; e-mail: mho{at}ucalgary.ca.
1. World Health Organization. Malaria. WHO Fact Sheet. 1995;94:1-3. 2. Chotivanich K, Udomsangpetch R, Simpson JA, et al. Parasite multiplication potential and the severity of Falciparum malaria. J Infect Dis. 2000;181:1206-1209[Medline] [Order article via Infotrieve]. 3. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria: a quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol. 1985;119:385-401[Abstract]. 4. White NJ, Ho M. The pathophysiology of malaria. Adv Parasitol. 1992;31:83-173[Medline] [Order article via Infotrieve]. 5. Cooke BM, Brendt AR, Craig AG, MacGregor J, Newbold CI, Nash GB. Rolling and stationary cytoadhesion of red blood cells parasitised by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin. Br J Haematol. 1994;87:162-170[Medline] [Order article via Infotrieve]. 6. Udomsangpetch R, Reinhardt PH, Schollaardt T, Elliott JF, Kubes P, Ho M. Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol. 1997;158:4358-4364[Abstract].
7.
Ho M, Schollaardt T, Niu X, Looareesuwan S, Patel KD, Kubes P.
Characterization of Plasmodium falciparum-infected erythrocytes and P-selectin interaction under flow conditions.
Blood.
1998;91:4803-4809 8. Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW, Lawley TJ. Regulation of vascular adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol. 1992;149:698-705[Abstract].
9.
Yao L, Pan J, Setiadi H, Patel KD, McEver RP.
Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells.
J Exp Med.
1996;184:81-92 10. McCormick CJ, Craig A, Roberts D, Newbold CI, Berendt AR. Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. J Clin Invest. 1997;100:2521-2529[Medline] [Order article via Infotrieve].
11.
Ockenhouse CF, Tegoshi T, Maeno Y, et al.
Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1.
J Exp Med.
1992;176:1183-1189 12. Johnson-Tidey RR, McGregor JL, Taylor PR, et al. Increase in the adhesion molecule P-selectin in endothelium overlaying atherosclerotic plaques: co-expression with intercellular adhesion molecule-1. Am J Pathol. 1994;144:952-961[Abstract]. 13. Palabrica T, Lobb R, Furie BC. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-850[Medline] [Order article via Infotrieve]. 14. Larsen E, Celi A, Gilbert GE, et al. A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989;59:305-312[Medline] [Order article via Infotrieve]. 15. Esmon CT, Esmon NL, Le Bonniec BF, Johnson AE. Protein C activation. Methods Enzymol. 1993;222:359-268[Medline] [Order article via Infotrieve].
16.
Patel KD, Nollert MU, McEver RP.
P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils.
J Cell Biol.
1995;131:1893-1902 17. Petzelbauer P, Bender JR, Wilson J, Pober JS. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell cultures. J Immunol. 1993;151:5062-5072[Abstract]. 18. Turner GDH, Morrison H, Jones M, et al. An immunohistochemical study of the pathology of fatal malaria. Am J Pathol. 1994;145:1057-1069[Abstract].
19.
Steerber DA, Campbell MA, Basir A, Ley K, Tedder TF.
Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression.
Proc Natl Acad Sci U S A.
1998;95:7562-7567 20. Modur V, Feldhaus MJ, Weyrich A, et al. Oncostatin M is a proinflammatory mediator. J Clin Invest. 1997;100:158-168[Medline] [Order article via Infotrieve]. 21. Day NPJ, Hien TT, Schollaardt T, et al. The prognostic and pathophysiological role of pro- and anti-inflammatory cytokines in severe malaria. J Infect Dis. 1999;180:1288-1297[Medline] [Order article via Infotrieve]. 22. Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest. 1997;100:2752-2756[Medline] [Order article via Infotrieve].
23.
Magowan C, Wollish W, Anderson L, Leech JA.
Cytoadherence by Plasmodium falciparuminfected erythrocytes is correlated with the expression of a family of variable proteins on infected erythrocytes.
J Exp Med.
1988;168:1307-1320
24.
Baruch DI, Gormley JA, Ma C, Howard RJ, Pasloske BL.
Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.
Proc Natl Acad Sci U S A.
1996;93:3497-3502 25. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science. 1996;272:1502-1504[Abstract].
26.
Baruch DI, Ma XC, Singh HB, Bi X, Pasloske BL, Howard RJ.
Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence.
Blood.
1999;90:3766-3775
27.
Smith JD, Craig AG, Kriek N, et al.
Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria.
Proc Natl Acad Sci U S A.
2000;97:1766-1771
28.
Reeder JC, Cowman AF, Davern KM, et al.
The adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1.
Proc Natl Acad Sci U S A.
1999;96:5198-5202 29. Treutiger CJ, Heddini A, Fernandes V, Muller WA, Wahlgren M. PECAM- 1/CD31, an endothelial receptor for binding Plasmodium falciparuminfected erythrocytes. Nat Med. 1997;3:1405-1408[Medline] [Order article via Infotrieve].
30.
Siano JP, Grady KK, Millet P, Wick TM.
Plasmodium falciparum cytoadherence to
31.
Cranston HA, Boylan CW, Carroll GL, et al.
Plasmodium falciparum maturation abolishes physiologic red cell deformability.
Science.
1984;223:400-402 32. Looareesuwan S, Ho M, Wattanagoon Y, et al. Dynamic alterations in splenic function in falciparum malaria. N Engl J Med 1987;31:675-679.
© 2000 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  R. Cholera, N. J. Brittain, M. R. Gillrie, T. M. Lopera-Mesa, S. A. S. Diakite, T. Arie, M. A. Krause, A. Guindo, A. Tubman, H. Fujioka, et al. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin PNAS, January 22, 2008; 105(3): 991 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Gillrie, G. Krishnegowda, K. Lee, A. G. Buret, S. M. Robbins, S. Looareesuwan, D. C. Gowda, and M. Ho Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins Blood, November 1, 2007; 110(9): 3426 - 3435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Fraser, C. M. Cserti, and W. H. Dzik Case 32-2006 -- A 3-Year-Old Girl with Fever after a Visit to Africa N. Engl. J. Med., October 19, 2006; 355(16): 1715 - 1722. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ho, H. L. Hoang, K. M. Lee, N. Liu, T. MacRae, L. Montes, C. L. Flatt, B. G. Yipp, B. J. Berger, S. Looareesuwan, et al. Ectophosphorylation of CD36 Regulates Cytoadherence of Plasmodium falciparum to Microvascular Endothelium under Flow Conditions Infect. Immun., December 1, 2005; 73(12): 8179 - 8187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. WHITE DYNAMIC DETERMINANTS OF THE CYTOADHERENCE OF PLASMODIUM FALCIPARUM-INFECTED ERYTHROCYTES Am J Trop Med Hyg, June 1, 2005; 72(6): 658 - 659. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Serirom, W. H. Raharjo, K. Chotivanich, S. Loareesuwan, P. Kubes, and M. Ho Anti-Adhesive Effect of Nitric Oxide on Plasmodium falciparum Cytoadherence under Flow Am. J. Pathol., May 1, 2003; 162(5): 1651 - 1660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Yipp, S. M. Robbins, M. E. Resek, D. I. Baruch, S. Looareesuwan, and M. Ho Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow Blood, April 1, 2003; 101(7): 2850 - 2857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Yipp, D. I. Baruch, C. Brady, A. G. Murray, S. Looareesuwan, P. Kubes, and M. Ho Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo Blood, January 1, 2003; 101(1): 331 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Yipp, G. Andonegui, C. J. Howlett, S. M. Robbins, T. Hartung, M. Ho, and P. Kubes Profound Differences in Leukocyte-Endothelial Cell Responses to Lipopolysaccharide Versus Lipoteichoic Acid J. Immunol., May 1, 2002; 168(9): 4650 - 4658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Weatherall, L. H. Miller, D. I. Baruch, K. Marsh, O. K. Doumbo, C. Casals-Pascual, and D. J. Roberts Malaria and the Red Cell Hematology, January 1, 2002; 2002(1): 35 - 57. [Abstract] [Full Text]
|
|
|
|
|
|
P. Gruarin, L. Primo, C. Ferrandi, F. Bussolino, N. N. Tandon, P. Arese, D. Ulliers, and M. Alessio Cytoadherence of Plasmodium falciparum-Infected Erythrocytes Is Mediated by a Redox-Dependent Conformational Fraction of CD36 J. Immunol., December 1, 2001; 167(11): 6510 - 6517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Senczuk, J. C. Reeder, M. M. Kosmala, and M. Ho Plasmodium falciparum erythrocyte membrane protein 1 functions as a ligand for P-selectin Blood, November 15, 2001; 98(10): 3132 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Matsui, L. Borsig, S. D. Rosen, M. Yaghmai, A. Varki, and S. H. Embury P-selectin mediates the adhesion of sickle erythrocytes to the endothelium Blood, September 15, 2001; 98(6): 1955 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ho, M. J. Hickey, A. G. Murray, G. Andonegui, and P. Kubes Visualization of Plasmodium falciparum-Endothelium Interactions in Human Microvasculature: Mimicry of Leukocyte Recruitment J. Exp. Med., October 16, 2000; 192(8): 1205 - 1212. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2000 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
3 that
interact with IRBCs,